Bausch Health Companies (BHC) Receivables (2009 - 2026)

Bausch Health Companies has disclosed Receivables across 18 years of filings, most recently posting $2.3 billion for Q2 2026.

• In Q2 2026, Receivables rose 2.4% year-over-year to $2.3 billion; the TTM figure through Jun 2026 stood at $2.3 billion (up 2.4% YoY), while the FY2025 annual figure was $2.4 billion, up 9.86% from the prior year.
• Receivables came in at $2.3 billion for Q2 2026 at Bausch Health Companies, up from $2.2 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $2.4 billion in Q3 2025 to a low of $1.6 billion in Q1 2022.
• Average Receivables over 5 years is $2.0 billion, with a median of $2.1 billion recorded in 2024.
• Year-over-year, Receivables grew 0.52% in 2022 and gained 21.33% in 2024.
• Over 5 years, Receivables stood at $1.8 billion in 2022, then gained by 11.62% to $2.0 billion in 2023, then gained by 7.11% to $2.1 billion in 2024, then gained by 9.86% to $2.4 billion in 2025, then dropped by 3.74% to $2.3 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $2.3 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.4 billion in Q4 2025.